Abstract

BackgroundCommercial bacterins are widely used at weaning to control Mycoplasma hyopneumoniae infections in pigs. However, it is not known whether the efficacy of vaccinating against M. hyopneumoniae can be influenced by the weaning process when vaccination is applied at the day of weaning. The present study assessed the efficacy of a single M. hyopneumoniae vaccination (Ingelvac MycoFLEX®) three days before weaning (V1) or at weaning (V2) against experimental challenge infection. Four weeks after vaccination, groups V1 and V2 (n = 20 pigs each) and a non-vaccinated, positive control group (PCG) (n = 20) were endotracheally inoculated with a virulent M. hyopneumoniae field strain. Five pigs were used as a negative control group. All pigs were euthanized 5 weeks after challenge. The main parameters investigated included macroscopic and histopathological lung lesions at necropsy, immunofluorescence (IF) staining and quantitative real-time PCR (qPCR) on broncho-alveolar lavage (BAL) fluid for quantifying M. hyopneumoniae.ResultsThe average macroscopic lung lesion scores in groups V1, V2 and PCG were 0.54, 0.88 and 1.04, respectively (P > 0.05). The average lymphohistiocytic infiltration scores in groups V1, V2 and PCG were 2.95, 3.16 and 3.61, respectively (P < 0.05). The average IF scores were: V1 = 1.13, V2 = 1.19 and PCG = 1.25 (P > 0.05), the qPCR values were: V1 = 102.94, V2 = 102.76 and PCG = 103.23 (P > 0.05). All pigs of the negative control group remained negative throughout the study.ConclusionsBoth vaccinated groups had lower numbers of macroscopic and histopathological lung lesions, and lower numbers of M. hyopneumoniae organisms in the BAL fluid compared to the PCG. However, no firm conclusions could be made on whether weaning negatively influences the efficacy of M. hyopneumoniae vaccination, since significant differences between the treatment groups were only obtained for the histopathological lung lesions. This could be attributed to the fact that milder macroscopic lung lesions were produced in the inoculated pigs, when compared to previous trials conducted by the same group. Further research under field conditions is warranted to assess possible differences between the two vaccination strategies.

Highlights

  • Commercial bacterins are widely used at weaning to control Mycoplasma hyopneumoniae infections in pigs

  • M. hyopneumoniae is an important pathogen involved in the porcine respiratory disease complex (PRDC) [5, 6]

  • One important question that remains to be answered, and whose answer could contribute to the optimization of existing vaccination schemes, is whether the efficacy of vaccinating against M. hyopneumoniae can be influenced by the weaning process when vaccination is applied at the day of weaning

Read more

Summary

Introduction

Commercial bacterins are widely used at weaning to control Mycoplasma hyopneumoniae infections in pigs. M. hyopneumoniae infections have been detected in almost all countries with intensive production systems and are responsible for major economic losses in the pig industry [1, 3]. These economic losses are due to pig growth retardation, higher feed conversion ratios, increased antimicrobial use and increased susceptibility to other respiratory pathogens such as Pasteurella multocida, Actinobacillus pleuropneumoniae, Trueperella pyogenes and Streptococcus suis [4]. More than 70 % of pig herds are vaccinated against M. hyopneumoniae in an effort to control the disease [7]. Different vaccination schemes can be implemented, depending on the type of herd, the production system, the infection pattern and the preference of the farmer

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call